Patricia Diaz-Galvan

Patricia Diaz-Galvan

Auto-generated profile, based on publicly available information

Patricia Diaz-Galvan

Unidad de Trastornos del Movimiento, Servicio de Neurología, Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Spain

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 March 2019 in Journal of Alzheimer’s Disease
Verified
Journal Article
Closed access
PDF file
NCNira Cedres
Nira Cedres
AMAlejandra Machado
Alejandra Machado
YMYaiza Molina
Yaiza Molina
PDPatricia Diaz-Galvan
Patricia Diaz-Galvan
JHJuan Andres Hernández-Cabrera
Juan Andres Hernández-Cabrera
DFDaniel Ferreira
Daniel Ferreira
Subjective cognitive complaints in cognitively normal individuals are a relevant predictor of Alzheimer’s disease (AD), cerebrovascular disease, and age-related tauopathy. Complaints starting after the age of 60 increase the likelihood of preclinical

8 February 2024 in Alzheimer's & Dementia
Verified
Journal Article
Open access
PDPatricia Diaz‐Galvan
Patricia Diaz‐Galvan
SPScott A. Przybelski
Scott A. Przybelski
AAAlicia Algeciras‐Schimnich
Alicia Algeciras‐Schimnich
DFDan J. Figdore
Dan J. Figdore
TLTimothy G. Lesnick
Timothy G. Lesnick
KKKejal Kantarci
Kejal Kantarci
INTRODUCTION: Patients with dementia with Lewy bodies (DLB) may have Alzheimers disease (AD) pathology that can be detected by plasma biomarkers. Our objective was to evaluate plasma biomarkers of AD and their association with positron emission tomography (PET) biomarkers of amyloid and tau deposition in the continuum of DLB, starting from prodromal stages of the disease.METHODS: The cohort included patients with isolated rapid eye movement (REM) sleep behavior disorder (iRBD), mild cognitive impairment with Lewy bodies (MCI‐LB), or DLB, with a concurrent blood draw and PET scans.RESULTS: Abnormal levels of plasma glial fibrillary acidic protein (GFAP) were found at the prodromal stage of MCI‐LB in association with increased amyloid PET. Abnormal levels of plasma phosphorylated tau (p‐tau)‐181 and neurofilament light (NfL) were found at the DLB stage. Plasma p‐tau‐181 showed the highest accuracy in detecting abnormal amyloid and tau PET in patients with DLB.DISCUSSION: The range of AD co‐pathology can be detected with plasma biomarkers in the DLB continuum, particularly with plasma p‐tau‐181 and GFAP.

20 January 2023 in npj Parkinson's Disease
Verified
Journal Article
Open access
PDF file
AIAnna Inguanzo
Anna Inguanzo
KPKonstantinos Poulakis
Konstantinos Poulakis
RMRosaleena Mohanty
Rosaleena Mohanty
CSChristopher G. Schwarz
Christopher G. Schwarz
SPScott A. Przybelski
Scott A. Przybelski
DFDaniel Ferreira
Daniel Ferreira
Dementia with Lewy bodies (DLB) is a neurodegenerative disorder with a wide heterogeneity of symptoms, which suggests the existence of different subtypes. We used data-driven analysis of magnetic resonance imaging (MRI) data to investigate DLB subtypes. We included 165 DLB from the Mayo Clinic and 3 centers from the European DLB consortium and performed a hierarchical cluster analysis to identify subtypes based on gray matter (GM) volumes. To characterize the subtypes, we used demographic and clinical data, as well as β-amyloid, tau, and cerebrovascular biomarkers at baseline, and cognitive decline over three years. We identified 3 subtypes: an older subtype with reduced cortical GM volumes, worse cognition, and faster cognitive decline (n = 49, 30%); a subtype with low GM volumes in fronto-occipital regions (n = 76, 46%); and a subtype of younger patients with the highest cortical GM volumes, proportionally lower GM volumes in basal ganglia and the highest frequency of cognitive fluctuations (n = 40, 24%). This study shows the existence of MRI subtypes in DLB, which may have implications for clinical workout, research, and therapeutic decisions.

25 August 2021 in Aging
Verified
Journal Article
Open access
NCNira Cedres
Nira Cedres
PDPatricia Diaz-Galvan
Patricia Diaz-Galvan
LDLucio Diaz-Flores
Lucio Diaz-Flores
JMJ-Sebastian Muehlboeck
J-Sebastian Muehlboeck
YMYaiza Molina
Yaiza Molina
DFDaniel Ferreira
Daniel Ferreira
Aims: To investigate the interplay between gray matter (GM) and white matter (WM) neurodegeneration in subjective cognitive decline (SCD), including thickness across the whole cortical mantle, hippocampal volume, and integrity across the whole WM.

23 June 2025 in Movement Disorders
Verified
Journal Article
Open access
PDPatricia Diaz‐Galvan
Patricia Diaz‐Galvan
SPScott A. Przybelski
Scott A. Przybelski
TLTimothy G. Lesnick
Timothy G. Lesnick
MMMelissa E. Murray
Melissa E. Murray
ANAivi Nguyen
Aivi Nguyen
KKKejal Kantarci
Kejal Kantarci
Objective: To compare iron deposition in the substantia nigra (SN) as measured with quantitative susceptibility mapping (QSM) on antemortem magnetic resonance imaging (MRI) between individuals with and without Lewy‐related pathology at autopsy. Methods: We performed a retrospective cohort study including 54 participants who underwent autopsy and antemortem MRI with QSM. Cases were classified as Lewy body disease (LBD)‐present (n = 13) if they had Lewy‐related pathology and LBD‐absent (n = 41) if they did not have Lewy‐related pathology. QSM was calculated for the whole SN and the two subregions: pars compacta (SNc) and pars reticulata (SNr). Nonparametric Wilcoxon rank‐sum tests were used to compare SN QSM values between LBD‐present and LBD‐absent cases. Area under the receiver operating characteristic (ROC) curve (AUC) analyses tested the accuracy of SN QSM values to distinguish the two groups. Associations of QSM values in the SN and its subregions with clinical features were tested with Spearman's correlations. Results: The LBD‐present group had higher QSM values in the SNc ( P = 0.008) than the LBD‐absent group with no differences in SNr. QSM values of the SNc distinguished LBD‐present and LBD‐absent cases with good accuracy (AUC = 0.74) and correlated with the presence of parkinsonism and parkinsonism severity. Conclusions: This study provides neuropathological confirmation of the utility of SNc QSM as an in vivo biomarker of Lewy‐related pathology. Imaging evidence of abnormal iron deposition in the SNc could potentially serve as a biomarker for inclusion in emerging research frameworks aimed at defining individuals with LBD based on their biological characteristics. Ultimately, this could facilitate more precise diagnoses and guide treatment strategies in LBD. © 2025 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

9 September 2025 in Neurology
Verified
Journal Article
Closed access
PDPatricia Diaz-Galvan
Patricia Diaz-Galvan
PFPablo Franco-Rosado
Pablo Franco-Rosado
JSJesus Silva-Rodriguez
Jesus Silva-Rodriguez
SCSandra Castro-Labrador
Sandra Castro-Labrador
MLMiguel A. Labrador-Espinosa
Miguel A. Labrador-Espinosa
PMPablo Mir
Pablo Mir
Accumulating evidence suggests that physical activity is associated with a better clinical and cognitive course in Parkinson disease (PD), yet whether these effects are subserved by structural brain alterations are largely unexplored. The aim of this study was to investigate whether regular physical activity associates with a reduced longitudinal rate of neurodegeneration and slower cognitive decline in PD. In this longitudinal, observational cohort study, we used data from the Parkinson's Progression Markers Initiative. We included patients with early PD who had serial assessments of regular physical activity, measured using the Physical Activity Scale for the Elderly, along with serial MRI scans from at least 2 time points over 4 years of follow-up. Regional cortical thickness and subcortical volumes were calculated using established procedures. We used multivariate linear mixed-effects models to analyze the effect of regular physical activity on the progression of MRI parameters over time. We further used mediation models with nonparametric bootstrap to test mediation effects of longitudinal structural brain changes on the association between regular physical activity and longitudinal cognitive functioning. A total of 120 patients with early PD were included (mean [SD] age = 60.8 [9.3] years; 33% women). Average regular physical activity levels over time were significantly associated with slower cortical thinning in temporoparietal cortical regions, including the lateral temporal cortex, the fusiform gyrus, the parahippocampal gyrus, and the inferior parietal cortex (p < 0.05). Regular physical activity levels over time were also associated with slower volume loss in the hippocampus and the amygdala (p < 0.05). The association of regular physical activity with slower decline in memory and attention functions was mediated by slower decreases in temporoparietal cortical thickness (βPASE-HVLT, = 0.06, p = 0.050; βPASE-SDMT = 0.04, p = 0.017) and hippocampal volume (βPASE-SDMT = 0.03, p = 0.016). Regular physical activity is associated with a slower rate of neurodegeneration in the temporoparietal cortex and limbic areas in PD, which contributes to preserved cognitive function and improved long-term outcomes. This supports regular physical activity as a key intervention to delay disease progression and improve quality of life in patients with PD.